Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

U.S. Issues Final Rules Implementing No Surprises Act and Modifying Dispute Resolution Process

By Monica Nugent & Shannon D. Farmer on August 26, 2022
Email this postTweet this postLike this postShare this post on LinkedIn

On August 19, 2022, the U.S. Departments of Labor, Treasury, and Health & Human Services issued final rules entitled, “Requirements Related to Surprise Billing: Final Rules,” which modify the independent dispute resolution (IDR) process implemented under the No Surprises Act. 

The No Surprises Act (the Act), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), created novel protections against out-of-network balance billing and established an IDR process for resolving payment disputes between certain providers and health plans when they are unable to agree upon an appropriate price for out-of-network services.  Following challenges in the Eastern District of Texas – which resulted in the court vacating key aspects of the interim rules governing dispute resolution – the Departments issued their new regulations finalizing portions of the previous rules on the controversial IDR process. 

Under the new rules, the IDR process seeks to ensure transparency in the qualifying payment amount (QPA) calculation process as it relates to the practice of “downcoding,” which occurs when plans and issuers manipulate the QPA by using different service codes than the codes providers originally used in billing.  Employers and sponsors of group health plans should prepare themselves to implement and comply with these new rules by consulting with claims administrators and counsel. 

For additional information, please see the full Legal Alert prepared by our Health Care and Employee Benefits and Executive Compensation colleagues, who regularly advise plan sponsors and plan administrators navigating these laws.

  • Posted in:
    Health Care and Life Sciences
  • Blog:
    HR Law Watch
  • Organization:
    Ballard Spahr LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo